Published in:
Open Access
01-12-2018 | Commentary
Does glucagon have a positive inotropic effect in the human heart?
Author:
Jesus Hernández-Cascales
Published in:
Cardiovascular Diabetology
|
Issue 1/2018
Login to get access
Abstract
Glucagon is considered to exert cardiostimulant effects, most notably the enhancement of heart rate and contractility, due to the stimulation of glucagon receptors associated with Gs protein stimulation which causes adenylyl cyclase activation and the consequent increase in 3′,5′-cyclic adenosine monophosphate production in the myocardium. These effects have been extensively demonstrated in experimental studies in different animal species. However, efforts to extrapolate the experimental data to patients with low cardiac output states, such as acute heart failure or cardiogenic shock, have been disappointing. The experimental and clinical data on the cardiac effects of glucagon are described here.